Antitrust probe spurs disease review
The Infectious Diseases Society of America (IDSA) has agreed to reassess controversial treatment guidelines for Lyme disease after an unprecedented antitrust investigation was launched against the group last year, according to the linkurl:Wall Street Journal Health Blog.;https://blogs.wsj.com/health/2008/05/01/guidelines-for-lyme-disease-treatment-go-back-for-review/?mod=WSJBlog Connecticut Attorney General Richard Blumenthal linkurl:launched the investigation;https://www.the-scientist.com/news/d
Written byElie Dolgin
| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
Interested in reading more?
The Scientist ARCHIVES
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred Google source to see more of our trusted coverage.
Meet the Author
- This person does not yet have a bio.View Full Profile
